Bluejay Diagnostics (BJDX) Total Current Liabilities (2021 - 2026)

Bluejay Diagnostics' Total Current Liabilities history runs 6 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 7.39% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 7.39% YoY), while the FY2025 annual figure was $1.1 million, up 38.11% from the prior year.
• Total Current Liabilities came in at $1.4 million for Q1 2026 at Bluejay Diagnostics, up from $1.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $2.8 million in Q3 2023 to a low of $810368.0 in Q4 2024.
• A 5-year average of $1.5 million and a median of $1.4 million in 2026 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities soared 157.43% in 2022 and slumped 64.29% in 2024, its largest moves.
• Bluejay Diagnostics' Total Current Liabilities stood at $1.6 million in 2022, then increased by 7.99% to $1.8 million in 2023, then tumbled by 54.25% to $810368.0 in 2024, then surged by 38.11% to $1.1 million in 2025, then increased by 26.33% to $1.4 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $1.4 million, $1.1 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison